Department of Medicine
Faculty Profiles by Division

Division of Cardiology

Faculty Profiles

[Return To Index page]
photo Suresh Mulukutla, MD

Associate Professor of Medicine

Email: mulukutlasr@upmc.edu

Phone: 412-647-1056

Contact
Office: Heart & Vascular Institute, UPMC Presbyterian
200 Lothrop St.
Pittsburgh, PA 15213
 
Phone: 412-647-1056
Fax: 412-648-6101
E-mail: mulukutlasr@upmc.edu
Administrative Assistant:
Amanda Bisesi
Email: bisesia@upmc.edu
Phone: 412-647-7718
Fax: 412-648-6101
Education and Training
Education
BA, Cornell University, 1993
MD, Cornell University Medical College, 1996
Certificate in Clinical Research, University of Pittsburgh, 2004
Training
Internship/Residency - Internal Medicine, Boston Medical Center - Boston University, 1999
Cardiovascular Fellowship, University of Pittsburgh Medical Center, 2002
Interventional Cardiology Fellowship, University of Pittsburgh Medical Center, 2003
Research Interest
Dr. Mulukutla has established himself as a well-recognized investigator in the field of cardiovascular outcomes research. His early involvement with the Dynamic Registry has resulted in several high-impact publications. He has contributed several other papers based upon the Dynamic Registry as first author, senior author, and co-author, which has earned him recognition in the Interventional Cardiology community. It was this work that largely led him to be recognized by Cardiovascular Research Technologies as one of the nation’s “Young Leaders” in 2009.
He has taken on an increased role in using system wide data across the UPMC Health System to identify opportunities for operational improvements and efficiencies within the Heart and Vascular Institute while simultaneously providing high level care to our patients. He focuses on the evaluation of cardiovascular outcomes with focus on clinical end points, cost-effectiveness, patient preferences, and quality of life as well as issues surrounding the development, introduction, and use of medical technology.
Currently, he oversees HVI Analytics and directs the HVI Center for Outcomes and Innovation. This has been responsible for the foundation for several initiatives across the health system to improve care as well as academic and research activities in outcomes across HVI. In this role, him and his team in collaboration with UPMC Clinical Analytics help others within HVI in the creation of dashboards to understand care processes and in developing datasets for analysis. These revolve around areas of clinical decision-making, readmissions in heart failure populations, treatment of complex coronary artery disease, among others.
Clinical Interest
Dr. Mulukutla's clinical area of interest is in Interventional Cardiology. His focus is on the treatment of coronary artery disease and the risk factors that lead to this condition, including hyperlipidemia, hypertension among others. He has an interest in treating patients with complex coronary disease and those presenting with acute myocardial infarction.
Educational Interest
Dr. Mulukutla's educational interest revolves around general and interventional cardiology. He is dedicated to teaching fellows in the cardiac catheterization environment where he works closely with them in training them in both the technical and interpretive aspects of coronary angiography and interventions. In addition, he has spent time in didactic teaching to general and interventional fellows. He has worked with 2nd year medical students during their Cardiology subsection. Moreover, Dr. Mulukutla serves as a mentor for numerous medical students, residents, fellows, and he serves on the Masters and PhD thesis committees for numerous students in the Graduate School of Public Health.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Sanchez CE, Dota A, Badhwar V, Kliner D, Smith AJ, Chu D, Toma C, Wei L, Marroquin OC, Schindler J, Lee JS, Mulukutla SR. Revascularization heart team recommendations as an ad-junct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease. Catheter Cardiovasc Interv. 2015; PMID 26527352.
Chu D, Anastacio MM, Mulukutla SR, Lee JS, Smith AJ, Marroqin OC, Sanchez CE, Morell VO, Cook CC, Lico SC, Wei LM, Badhwar V. Safety and efficacy of implementing a multidis-ciplinary heart team approach for revascularization in patients with complex coronary artery dis-ease: an observational cohort pilot study. JAMA Surg. 2014; 149(11)__PMID: 25207883: 1109-12.
Sanchez CE, Badhwar V, Dota A, Schindler J, Chu D, Smith AJ, Lee JS, Khandhar S, Tomas C, Marroquin OC, Schmidhofer M, Bhama J, Wei L, Scolieri S, Esper S, Lee A, Mulukutla SR. Practical implementation of the coronary revascularization heart team. Circ Cardiovasc Qual Outcomes. 2013; 6(5): 598-603.
Mulukutla SR, Marroquin OC, Vlachos HA, Selzer F, Toma C, Kip KE, Abbott JD, Holper E, Lee JS, Khandhar S, Kutcher M, Kelsey S, Smith C, Faxon D, Williams DO. Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dy-namic registry. Am J Cardiol. 2013; 111(4): 486-92.
Mulukutla SR, Venkitachalam L, Bambs C, Kip KE, Aiyer A, Marroquin OC, Reis SE. Black race is associated with digital artery endothelial dysfunction: results from the Heart SCORE study. Eur Heart J. 2010; 31(22): 2808-15.
Wolf WM, Vlachos HA, Marroquin OC, Lee JS, Smith C, Anderson WD, Schindler JT, Holper EM, Abbott JD, Williams DO, Laskey WK, Kip KE, Kelsey SF, Mulukutla SR. Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circ Cardiovasc Interv. 2010; 3(1): 42-9.
Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey WK, Williams DO, Smith C, Anderson WD, Lee JS, Srinivas V, Kelsey SF, Kip KE. Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. JACC Cardiovasc Interv. 2008; 1(2): 139-47.
Mulukutla SR, Venkitachalam L, Marroquin OC, Kip KE, Aiyer A, Edmundowicz D, Ganesh S, Varghese R, Reis SE. Population variations in atherogenic dyslipidemia: A report from the HeartSCORE and IndiaSCORE Studies. J Clin Lipidol. 2008; 2(6): 410-7.
Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL, Tanguay JF, Holper EM, Abbott JD, Lee JS, Smith C, Anderson WD, Kelsey SF, Kip KE. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med. 2008; 358(4): 342-52.
Mulukutla SR, Marroquin OC, Smith C, Varghese R, Anderson WD, Lee JS, Cohen HA, Counihan PJ, Lee AB, Gulati V, McNamara D. Effect of statin therapy prior to elective percuta-neous coronary intervention on frequency of periprocedural myocardial injury. Am J Cardiol. 2004; 94(11): 1363-6.